Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Published:2018-12-04 Issue:3 Volume:9 Page:342-353
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Blombery Piers,Anderson Mary Ann,Gong Jia-nan,Thijssen Rachel,Birkinshaw Richard W.^ORCID,Thompson Ella R.,Teh Charis E.,Nguyen Tamia,Xu Zhen,Flensburg Christoffer,Lew Thomas E.,Majewski Ian J.,Gray Daniel H.D.,Westerman David A.^ORCID,Tam Constantine S.,Seymour John F.^ORCID,Czabotar Peter E.,Huang David C.S.^ORCID,Roberts Andrew W.^ORCID

Funder

Leukemia and Lymphoma Society

SCOR

Cancer Council Victoria

NHMRC

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations;Expert Review of Hematology;2024-09-13

2. SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma;Journal of Experimental Medicine;2024-09-05

3. Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction;Leukemia & Lymphoma;2024-09-04

4. Classification of Haematolymphoid Neoplasms: A work in progress towards more precise disease definitions in the era of precision oncology;The National Medical Journal of India;2024-08-26

5. Differential regulation of BAX and BAK apoptotic activity revealed by a novel small molecule;2024-08-05